MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Neuron specific protein S100B and cognitive impairment in various forms parkinsonism

    R.J. Matmurodov, K.M. Khalimova, N.S. Rashidova, U. Ergashev, O. Turgunhojayev (Tashkent, Uzbekistan)

    Objective: In Parkinson's disease (PD) in almost all patients at the early stages of developing cognitive impairment. Background: Study of the degree of cognitive impairment,…
  • 2016 International Congress

    Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists

    M.E. Mohammad, J.A. Vizcarra, K. O'Donnell, S. Patel, X. Garcia, X.X. Yu, K. Vlastaris, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)

    Objective: To evaluate the clinician response to Parkinson patients who developed behavioral side effects from dopamine agonists. Background: Side effects from dopamine agonists can be…
  • 2016 International Congress

    Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach

    E. Bereczki, R.M.M. Branca, P.T. Francis, J.H. Baek, J. Lehtio, D. Aarsland (Huddinge, Sweden)

    Objective: The aim of our study is to understand the role of synaptic dysfunction in cognitive decline by comparing the whole proteome of Parkinson's disease…
  • 2016 International Congress

    Decline in drawing ability associated with frontal dysfunction after subthalamic nucleus deep brain stimulation in Parkinson’s disease

    S. Hirano, S. Furukawa, M. Asahina, T. Yamamoto, T. Uchiyama, Y. Yamanaka, Y. Higuchi, T. Horikoshi, T. Uno, N. Saeki, S. Kuwabara (Chiba, Japan)

    Objective: The aim of the present study was to elucidate the properties of drawing ability in Parkinson's disease (PD) patients after bilateral subthalamic nucleus deep…
  • 2016 International Congress

    Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia

    H. Bejr-Kasem, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Perez-Perez, J. Marin-Lahoz, B. Pascual-Sedano, S. Martínez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: Based on the importance of progressive dysfunction of posterior cortical regions in cognitive deterioration in PD, we explored whether posterior cortical dysfunction in early…
  • 2016 International Congress

    Catechol-o-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson’s disease

    Y. Zhang, Y. Zhang, K. Nie, S. Feng, L. Wang, J. Zhao, Z. Huang, L. Wang (Guangzhou, People's Republic of China)

    Objective: The Catechol-O-Methyltransferase (COMT) Val158Met polymorphism has been proposed to be associated with increased risk of PD and have a specific impact on dopamine-mediated prefrontal…
  • 2016 International Congress

    Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease

    R. Morris, S. Lord, J. Bunce, D. Burn, L. Rochester (Newcastle-Upon-Tyne, United Kingdom)

    Objective: To explore current evidence of associations and predictors of gait and cognition in older adults and pathology to provide a clear understanding of current…
  • 2016 International Congress

    Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?

    M.R. Olchik, M. Ghisi, A. Freiry, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

    Objective: To verify if the verbal trail test can replace the written trail test, seeing that individuals with PD show considerable motor abnormalities that can…
  • 2016 International Congress

    Association or causation? Orthostatic hypotension and cognitive impairment in α-synucleinopathies: A systematic review

    S.J. Udow, A.E. Lang, M. Masellis (Toronto, ON, Canada)

    Objective: To systematically review the literature for evidence of an association between orthostatic hypotension (OH) and cognitive impairment (CI) in α-synucleinopathies and to discuss possible…
  • 2016 International Congress

    Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia

    R.R. Umarov, N.G. Sokhibnazarov (Tashkent, Uzbekistan)

    Objective: To study the value of various neuropsychological scales to determine the degree of cognitive dysfunction in patients with posttraumatic subcortical Parkinsonian dementia, during the…
  • « Previous Page
  • 1
  • …
  • 1480
  • 1481
  • 1482
  • 1483
  • 1484
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • A Case of Pregabalin induced Parkinsonism
  • A survey-based analysis of abnormal movements in patients with Postural Tachycardia Syndrome (PoTS)
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley